Sylatron
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Sylatron, covering 2017-04-28 to 2021-06-16. Get the full timeline:
Most recent: Clinical Trial Update: Intraperitoneal Infusion of Autologous Monocytes With Sylatron (Peginterferon Alfa-2b) and Actimmune (Interferon Gamma-1b) in Women With Recurrent or Refractory Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer [Phase 1]